Managing Risks in Health 2.0


By Neil Versel

September 9, 2008 | TORONTO—Interactive media with user-generated content, often generically referred to as Web 2.0, has taken off in health care in the last couple of years. But with all the options and convenience that blogs, wikis, social networking sites, chat rooms, and message boards have opened up for patients and providers alike, the technology known as health 2.0 or medicine 2.0 is not without risk.

“This opens up a multitude of opportunities for patients,” Kevin Clauson, associate professor of pharmacy practice and a specialist in drug information at Nova Southeastern University (Palm Beach Gardens, Fla.), said here Friday at the first Medicine 2.0 Congress, which attracted 180 people from 19 countries for an academic-level discussion on interactive health-IT. He noted that PatientsLikeMe has become a popular forum and virtual support group for those with serious health issues.

Health 2.0 also can open up organizations to embarrassment or possibly even legal liability when it comes to interaction between patients and practitioners. Clauson noted that pharmacists in the U.S. have a “duty to warn” if patients are put in potentially unsafe situations. But it is not clear, Clauson said, if this duty extends to patient-posted content that may indicate that person is taking drugs that may interact with each other.

As more providers move to electronic health records and personal health records that patients can view, the public might be surprised to learn that clinicians have their own form of derogatory slang. Clauson said some popular descriptions he has seen in medical charts include: “CLL” (“chronic low-life”), “LOBNH” (“lights on but nobody home”), and “grave dodger” to describe a chronically ill elderly patient. What happens if patients suddenly start reading such language?

Messages often do get muddled online. E-mails and blogs are wide open to misinterpretation, since it is difficult to communicate tone in typed text. “Poor communication is exacerbated by writing because most people don’t write very well,” Clauson added.

Sometimes, organizations may get hurt by poor judgment that is completely beyond their institutional control. Clauson highlighted a study published in the July issue of the Journal of General Internal Medicine that found that medical students at the University of Florida were less than discrete with some of their Facebook pages. Some belonged to groups called “Physicians Looking for Trophy Wives in Training” or “PIMP: Party of Important Male Physicians.” Others were pictured grabbing the breasts of classmates, visibly drunk, or wearing a lab coat that said “Kevorkian Medical Clinic.”

Clauson recommends that organizations educate their staff about some of the hazards associated with health 2.0 before minor gaffes become major problems. “It is possible to some extent to ameliorate these risks with good judgment and risk management,” he said.

 

 

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

sgi whp 2
Managing the Modern Genomics Data Flood
Sponsored by SGI

Managing and storing the perfect storm of multi-disciplined data pouring from next generation sequencers and other omics instruments is a central challenge in life sciences. Discover in this paper how the SGI ArcFiniti storage solution, optimized for unstructured genomics and life sciences data can: 

  • Reduce costs, proactively protect data integrity, and deliver the high performance I/O required for genomics data processing and analysis.  
  • Effectively manage capacities from 156TB to 1.4PB as a disk based, integrated hardware and software platform 


sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Life Science Webcasts & Podcasts

medidata podcast #8 Meeting Today’s Challenges in Clinical Trial Supply Management
Sponsored by: Medidata Solutions Worldwide  

Setting up and managing the clinical trial involves many complex procedures. Among the most challenging are planning and executing the logistics of the trial’s clinical supplies. This podcast focuses in depth on the following topics which trace current practices and future evolution of this crucial aspect of clinical trials:

  • Current practices in clinical trial logistics
  • Comparing advances in clinical supply practices to  other aspects of clinical trials 
  • Where current practices fall short of meeting the challenges
  • Trends and evolving improvements that may change the way logistics are conducted

Listen Now  


More Podcasts

Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 
Apply at http://jobs.tessella.com   

oxford nanopore logo 


Early Access Collaborations ManagersClick here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Click to  Apply  

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .